Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10453463 | 1.00 | TSHR (0.48) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL15320774 | 1.00 | TSHR (0.48) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL1421122 | 1.00 | TSHR (0.48) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL9800786 | 1.00 | TSHR (0.48) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL3390346 | 0.97 | TSHR (0.50) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL30619668 | 0.92 | TSHR (0.55) | TSHRALDH1A1PTPN1CA1CA2 | |
| Dimethylamine SCHEMBL4059229 | 0.91 | KCNN4 (0.41) | TSHRALDH1A1PTPN1LMNACA1 | |
| SCHEMBL11696796 | 0.90 | TSHR (0.52) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL673282 | 0.87 | LMNA (0.43) | LMNACA1CA2THRBNR1H2 | |
| SCHEMBL1421311 | 0.87 | KIF11 (0.56) | TSHRALDH1A1PTPN1KIF11MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157105-A | Method for defluorination of perfluoro and polyfluoroalkyl substances | 中国科学技术大学 | 2025-06-17 | — | — | CN | claimed |
| CN-120157105-A | Method for defluorination of perfluoro and polyfluoroalkyl substances | 中国科学技术大学 | 2025-06-17 | — | — | CN | disclosed |
| US-20240122065-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | TOSOH CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4198163-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | Tosoh Corporation (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-116157382-A | Material for metal patterning, amine compound, electronic device, and method for forming metal pattern | 东曹株式会社 | 2023-05-23 | — | — | CN | disclosed |
| US-20110137063-A1 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-06-09 | — | — | US | disclosed |
| EP-2297070-A2 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2011-03-23 | — | — | EP | disclosed |
| WO-2010000409-A2 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-01-07 | — | — | WO | disclosed |
| EP-0510448-B1 | Sulfonic acid esters of 2,4,6-tris-(2-hydroxy-ethoxy)-1,3,5-triazine, radiation-sensitive positive functioning mixture containing them and recording material | CLARIANT GMBH (DE) | 2000-03-01 | — | — | EP | disclosed |
| US-5981422-A | PERFLUOROALKYLPHTHALOCYANINATO METAL COMPLEX OR 20-TETRAKIS-PENTAFLUOROPHENYL PORPHYRIN METAL COMPLEX USED AS CATALYST | EXXON RESEARCH AND ENGINEERING CO. (US) | 1999-11-09 | — | — | US | disclosed |
| US-5463082-A | Fluorous multiphase systems | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| EP-0633062-A1 | Fluorous multiphase catalyst or reagent systems, and processes using them | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5314786-A | Positive-working radiation sensitive mixture comprising sulfonic acid esters of 2,4,6-tris-(2-hydroxyethoxy)-[1,3,5]triazine, and recording material containing these esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-05-24 | — | — | US | disclosed |
| EP-0510441-A1 | Positive-working radiation-sensitive composition and radiation-sensitive recording material produced therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | disclosed |
| EP-0510446-A1 | Negative-working radiation-sensitive composition and radiation-sensitive recording material produced therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | disclosed |
| EP-0510447-A2 | Negative-working radiation-sensitive composition and radiation-sensitive recording material produced therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | disclosed |
| EP-0510448-A1 | Sulfonic acid esters of 2,4,6-tris-(2-hydroxy-ethoxy)-1,3,5-triazine, radiation-sensitive positive functioning mixture containing them and recording material | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | disclosed |
| US-5113013-A | Reacting a Sulfonyl Halide with Aromatic Halide | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-05-12 | — | — | US | disclosed |
| EP-0114359-B1 | PROCESS FOR PREPARING PERFLUOROALKYL-SUBSTITUTED CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-31 | — | — | EP | disclosed |
| EP-0114359-A1 | Process for preparing perfluoroalkyl-substituted carbocyclic or heterocyclic compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137063-A1 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | PFAS, PFKFB2, PFKFB1 | TSHR 183/4885ALDH1A1 1252/4885PTPN1 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.